New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin

QR Code

New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin

Baptist GallwitzDept Medicine IV, T&uuml;bingen University, Otfried-M&uuml;ller-Str, 10, 72076 T&uuml;bingen, GermanyAbstract: Saxagliptin is a novel dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor) for the treatment of type 2 diabetes, with a duration profile for once dail...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Baptist Gallwitz
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2010
Sujets:	Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/7c898e859a724600b3976e93c46cb673
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

New treatments in the management of type 2 diabetes: a critical appraisal of saxagliptin
par: Gallwitz B
Publié: (2010)

Saxagliptin for type 2 diabetes
par: Antonio R Chacra, et autres
Publié: (2010)

Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetes
par: Maffioli P, et autres
Publié: (2011)

Saxagliptin for type 2 diabetes
par: Chacra
Publié: (2010)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
par: Jason Seewoodhary, et autres
Publié: (2010)

Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
par: Gallwitz B
Publié: (2013)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
par: Jean-Pierre Le Floch
Publié: (2010)

Risk management in the treatment of type 2 diabetes with pioglitazone
par: Giuseppe Derosa, et autres
Publié: (2009)

Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin
par: Yu H, et autres
Publié: (2017)

Type 2 diabetes in Brazil: epidemiology and management
par: Almeida-Pititto B, et autres
Publié: (2015)

Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
par: Rigato M, et autres
Publié: (2014)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
par: Joshua J Neumiller, et autres
Publié: (2010)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
par: Robert Moses
Publié: (2009)

Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations
par: Uy J, et autres
Publié: (2012)

Insulin detemir for the treatment of obese patients with type 2 diabetes
par: Hollander PA
Publié: (2012)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
par: Shannon A Miller, et autres
Publié: (2009)

Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations
par: Rosak C, et autres
Publié: (2012)

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
par: Anderson M, et autres
Publié: (2014)

Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes
par: Kim Y, et autres
Publié: (2012)

Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment
par: Scott D
Publié: (2013)

Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin
par: Stanley S Schwartz
Publié: (2010)

Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
par: Sosale A, et autres
Publié: (2015)

Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes
par: Kishimoto M
Publié: (2013)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
par: Holl, et autres
Publié: (2014)

Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
par: Jonathan K Reynolds
Publié: (2009)

Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
par: Nishio S, et autres
Publié: (2015)

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
par: AlMaatouq MA
Publié: (2012)

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
par: Lorber D
Publié: (2014)

Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy
par: Amy Fleischman, et autres
Publié: (2009)

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan
par: Al Sifri S
Publié: (2012)

Long-term safety and efficacy of insulin degludec in the management of type 2 diabetes
par: Thuillier P, et autres
Publié: (2015)

Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus
par: Whaley JM, et autres
Publié: (2012)

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus
par: Petersen AB, et autres
Publié: (2013)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
par: Irons BK, et autres
Publié: (2014)

Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
par: Paul Valensi
Publié: (2009)

Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting
par: Ofori SN, et autres
Publié: (2014)

Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
par: Irons BK, et autres
Publié: (2017)

Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
par: Mann KV, et autres
Publié: (2014)

Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes
par: Hoimark L, et autres
Publié: (2012)

Recent results of exenatide use as adjunctive therapy in the treatment of patients with type 2 diabetes
par: Peggy Soule Odegard, et autres
Publié: (2009)